AI Summary
We reviewed 10000 live results for hizentra 200mg/ml solution for subcutaneous injection and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Pharmaceutical Distribution.
Comparison Table
Source: DKSH Malaysia Sdn Bhd
Description
This 200mg/ml Hizentra solution is the Malaysian-registered formulation (MAL18016154ARZ) provided for replacement therapy in primary immunodeficiency and immunomodulatory therapy in CIDP. It is distributed via authorized healthcare channels by DKSH Malaysia.
Best for
Malaysian healthcare providers, local patient access, authorized pharmaceutical distribution and PI and CIDP therapy in Malaysia
Rating
Source: Roche
Description
A ready-to-use subcutaneous injection of tocilizumab available as a 162 mg / 0.9 mL solution in a single-use pre-filled syringe (PFS). This formulation allows for self-administration by patients with rheumatoid arthritis or juvenile idiopathic arthritis, providing a more flexible alternative to clinical infusion sessions. It is registered with the Thai FDA and offers a convenient delivery method for long-term chronic disease management.
Best for
Self-administration at home, Chronic RA maintenance, Patient convenience and Thailand registered biologics
Rating
Source: Takeda
Description
Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations.
Best for
primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference
Rating
| Compare | Hizentra 200mg/ml solution for subcutaneous injection | Actemra Subcutaneous (SC) Injection | Kiovig 100mg/mL Solution for Infusion |
|---|---|---|---|
| Source | DKSH Malaysia Sdn Bhd | Roche | Takeda |
| Description | This 200mg/ml Hizentra solution is the Malaysian-registered formulation (MAL18016154ARZ) provided for replacement therapy in primary immunodeficiency and immunomodulatory therapy in CIDP. It is distributed via authorized healthcare channels by DKSH Malaysia. | A ready-to-use subcutaneous injection of tocilizumab available as a 162 mg / 0.9 mL solution in a single-use pre-filled syringe (PFS). This formulation allows for self-administration by patients with rheumatoid arthritis or juvenile idiopathic arthritis, providing a more flexible alternative to clinical infusion sessions. It is registered with the Thai FDA and offers a convenient delivery method for long-term chronic disease management. | Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations. |
| Best for | Malaysian healthcare providers, local patient access, authorized pharmaceutical distribution and PI and CIDP therapy in Malaysia | Self-administration at home, Chronic RA maintenance, Patient convenience and Thailand registered biologics | primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Hizentra 200mg/ml solution for subcutaneous injection from DKSH Malaysia Sdn Bhd."
I picked this because This is the officially recognized and regulated supply for the Malaysian market, ensuring product safety and local registration compliance.
Share this search
Related Finds